Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$53,406,081
+$10,800,678 QoQ
Shares Held
210,285
+20.6% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#428
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STEPHENS INC /AR/ holds $244,605,118 across 14 Drug Manufacturers - General names. JNJ ranks #1 (21.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
210,285 | $53,406,081 | |
| 2 | LLY |
ELI LILLY & Co
|
37,094 | $44,491,660 | |
| 3 | MRK |
Merck & Co., Inc.
|
272,973 | $35,077,030 | |
| 4 | ABBV |
AbbVie Inc.
|
139,208 | $35,030,301 | |
| 5 | AMGN |
Amgen Inc
|
93,841 | $33,981,702 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
282,306 | $16,266,471 | |
| 7 | AZN |
Astrazeneca PLC
|
53,960 | $10,231,895 | |
| 8 | PFE |
Pfizer Inc
|
335,032 | $8,067,570 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,406,081 | 210,285 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $42,605,403 | 174,298 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $39,326,294 | 190,028 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $36,122,411 | 194,814 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $30,122,452 | 197,201 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $33,617,758 | 202,712 | Shares | Defined | 2025-05-01 | |
| 2024-12-31 | $29,263,567 | 202,348 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $32,664,003 | 201,555 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $23,176,006 | 158,566 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $28,601,068 | 180,802 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $31,618,533 | 201,726 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $32,992,678 | 211,831 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $35,768,872 | 216,100 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $33,389,480 | 215,416 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $40,133,643 | 227,193 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $34,895,002 | 213,608 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $38,265,653 | 215,569 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $38,263,425 | 215,897 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $35,964,046 | 210,230 | Shares | Defined | 2022-03-07 | |
| 2021-09-30 | $37,158,243 | 230,082 | Shares | Defined | 2021-10-27 | |
| 2021-06-30 | $39,949,450 | 242,500 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $35,806,277 | 217,866 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $33,178,379 | 210,817 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $29,915,053 | 200,934 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $27,939,805 | 198,676 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $26,831,033 | 204,614 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||